8039 — TAIFLEX Scientific Co Balance Sheet
0.000.00%
- TWD15.97bn
- TWD15.11bn
- TWD9.94bn
- 69
- 43
- 91
- 80
Annual balance sheet for TAIFLEX Scientific Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,962 | 3,573 | 2,322 | 1,993 | 3,120 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,237 | 4,014 | 3,730 | 3,869 | 3,882 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,582 | 9,557 | 7,913 | 7,375 | 8,776 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,558 | 3,731 | 4,287 | 4,892 | 5,010 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 11,532 | 14,075 | 12,848 | 13,031 | 14,527 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,806 | 2,935 | 2,069 | 4,103 | 2,826 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 4,072 | 6,310 | 4,939 | 5,044 | 3,883 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 7,460 | 7,765 | 7,908 | 7,987 | 10,644 |
| Total Liabilities & Shareholders' Equity | 11,532 | 14,075 | 12,848 | 13,031 | 14,527 |
| Total Common Shares Outstanding |